NSABP B-47/NRG Oncology Phase III Randomized Trial Comparing Adjuvant Chemotherapy With or Without Trastuzumab in High-Risk Invasive Breast Cancer Negative for HER2 by FISH and With IHC 1+ or 2
National Cancer Institute (NCI)
Louis Fehrenbacher; Reena S Cecchini; Charles E Geyer; Priya Rastogi; Joseph P Costantino; James N Atkins; John P Crown; Jonathan Polikoff; Jean-Francois Boileau; Louise Provencher; Christopher Stokoe; Timothy D Moore; André Robidoux; Patrick J Flynn; Virginia F Borges; Kathy S Albain; Sandra M Swain; Soonmyung Paik; Eleftherios P Mamounas; Norman Wolmark